Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
The summary for the Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS): The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will identify and evaluate potential risk factors contributing to Amyotrophic Lateral Sclerosis (ALS), with preferred focus on research proposals that will examine factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of three funding options, Funding Option A, Funding Option B, or Funding Option C. Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base, may be supported by limited and insufficient preliminary research, and are exploratory and developmental in nature. Funding Option C is intended to support research and better understanding of ALS risk including prevalence and incidence in communities such as racial and ethnic minority populations (e.g., Black or African American persons, Hispanic or Latino persons, Asian persons) and military veterans.
Federal Grant Title: | Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) |
Federal Agency Name: | Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-TS-25-036 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.061 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | November 4th, 2024 |
Original Application Deadline: | November 4th, 2024 |
Posted Date: | August 1st, 2024 |
Creation Date: | August 1st, 2024 |
Archive Date: | March 9th, 2025 |
Total Program Funding: | $7,500,000 |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | 8 |
Cost Sharing or Matching: | No |
Last Updated: | August 1st, 2024 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.) - Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Additional Information on Eligibility
- See Section III. Eligibility Information.
- Grant Announcement Contact
- Candis M. Hunter, PhD, MSPH, REHS
[email protected]
[email protected] - Similar Government Grants
- • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • Identify, Analyze, and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (...
- • PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • Cdc Public Health Research: Health Protection Research Initiative Graduate Training Progra...
- • Improving Public Health Practice through Translation Research (R18)
- • CDC Health Protection Research Initiative: Evaluation of Workplace Health Promotion Resear...
- More Grants from the Centers for Disease Control and Prevention ERA
- • Rigorously Evaluating Primary Prevention Strategies for Intimate Partner Violence and Sexu...
- • Formative Research of Community-led Primary Prevention Approaches to Address Elevated Risk...
- • Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populati...
- • Effectiveness Research to Prevent Polysubstance-Impaired Driving
- • Grants to Support New Investigators in Conducting Research Related to Preventing Interpers...